Meeting Coverage 2025

  • UCAN CAN-DU: Changing the Paradigm in Childhood Arthritis Toward a Cure

    UCAN CAN-DU: Changing the Paradigm in Childhood Arthritis Toward a Cure

    Rae Yeung, MD, PhD, and others from the Understanding Childhood Arthritis Network’s Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases will outline new developments in juvenile idiopathic arthritis (JIA) facilitated by a team science approach to translational research.

  • Opening Session Speaker Outlines Individual and Organizational Roles in Systemic Solutions to Foster Clinician Well-Being

    Opening Session Speaker Outlines Individual and Organizational Roles in Systemic Solutions to Foster Clinician Well-Being

    Thought leader Tait Shanafelt, MD, shared strategies for combating occupational distress and burnout, including ongoing development and support for a health system’s leaders and collaborative action planning at the individual unit level.

  • Noted Researcher Will Discuss Immune Mechanisms in SLE During Foundation Memorial Lecture Honoring Dr. Eng Tan

    Noted Researcher Will Discuss Immune Mechanisms in SLE During Foundation Memorial Lecture Honoring Dr. Eng Tan

    George C. Tsokos, MD, will discuss how the current understanding of the pathogenesis of systemic lupus erythematous has evolved over time and where future directions in research might lead.

  • Investigators to Give Update on ILD in Rheumatic Diseases

    Investigators to Give Update on ILD in Rheumatic Diseases

    Justin Oldham, MD, PhD, will discuss monitoring and multidisciplinary care for progressive pulmonary fibrosis in patients with rheumatic disease, and Erin Wilfong, MD, PhD, will explore combining clinical and biological features of interstitial lung disease to improve disease management.

  • Debate to Weigh Steroid Use in Childhood-Onset Lupus

    Debate to Weigh Steroid Use in Childhood-Onset Lupus

    Hermine I. Brunner, MD, MSc, MBA, and Emily von Scheven, MD, MAS, will explore the arguments for and against different approaches to corticosteroid use in pediatric patients with systemic lupus erythematous.

  • Thieves Markets Challenge Clinicians with Unusual Adult and Pediatric Cases

    Thieves Markets Challenge Clinicians with Unusual Adult and Pediatric Cases

    Featuring four cases apiece, each of these interactive sessions will explain how to arrive at the correct diagnosis when confronted with mimickers of common diseases, unusual genetic disorders, or an overlay of diseases.

  • Session to Introduce the ACR’s New SLE Guideline

    Session to Introduce the ACR’s New SLE Guideline

    Using a case-based format, Lisa Sammaritano, MD, and other panelists will demonstrate how to use the guideline in a clinical setting, highlighting updates for 2025, and describe how the new recommendations were developed.

  • Speakers to Outline Vaccination Strategies for the Immunocompromised

    Speakers to Outline Vaccination Strategies for the Immunocompromised

    Panelists, including Jin Kyun Park, MD, will discuss vaccine response in immunocompromised patients and vaccines as preventative care for those patients.

  • Panel to Explore New Horizons in PsA Management

    Panel to Explore New Horizons in PsA Management

    Jose U. Scher, MD, will discuss challenges associated with addressing early onset psoriatic arthritis (PsA). The session also will review therapies for managing PsA.

  • Experts to Share New Developments in the Treatment of Pulmonary Sarcoidosis

    Experts to Share New Developments in the Treatment of Pulmonary Sarcoidosis

    Presentations in this Sunday session will include an assessment of the latest advances in better understanding the multiple phenotypes of pulmonary sarcoidosis from Michelle Sharp, MD, MHS.